KDIGO Guidelines

After three years, a work group of 15 investigators and a five-member evidence review team have produced the definitive evidence base for our clinical practice of care of the kidney transplant recipient. More than 2,000 articles have been reviewed and the weight of evidence considered to bring you this guideline.

If you would like to download these KDIGO guidelines for your use, see below this message. You will be able to download the whole guideline or simply acccess the component you are interested in.

Bertram Kasiske, Martin Zeier and Jeremy Chapman
on behalf of the KDIGO and The Transplantation Society

Download the entire guideline (PDF)

KDIGO guidelines - By chapter

Front Matter Download PDF
  • • Disclaimer
  • • Work Group Membership
  • • KDIGO Board Members
  • • Abbreviations and Acronyms
  • • Reference Keys
  • • Abstract
  • • Foreword
  • • Guideline Scope and Intended Users
Section I - Introduction: Immunosuppression Download PDF
  • • Chapter 1: Induction Therapy Download PDF
  • • Chapter 2: Initial Maintenance Immunosuppressive Medications Download PDF
  • • Chapter 3: Long-Term Maintenance Immunosuppressive Medications Download PDF
  • • Chapter 4: Strategies to Reduce Drug Costs Download PDF
  • • Chapter 5: Monitoring Immunosuppressive Medications Download PDF
  • • Chapter 6: Treatment of Acute Rejection Download PDF
  • • Chapter 7: Treatment of Chronic Allograft Injury Download PDF
Section II - Introduction: Graft Monitoring and Infections Download PDF
  • • Chapter 8: Monitoring Kidney Allograft Function Download PDF
  • • Chapter 9: Kidney Allograft Biopsy Download PDF
  • • Chapter 10: Recurrent Kidney Disease Download PDF
  • • Chapter 11: Preventing, Detecting, and Treating Nonadherence Download PDF
  • • Chapter 12: Vaccination Download PDF
  • • Chapter 13: Viral Diseases Download PDF
  •       - 13.1: BK Polyoma Virus
  •       - 13.2: Cytomegalovirus
  •       - 13.3: Epstein-Barr Virus and Post-Transplant Lymphoproliferative Disease
  •       - 13.4: Herpes Simplex Virus 1, 2 and Varicella Zoster Virus
  •       - 13.5: Hepatitis C Virus
  •       - 13.6: Hepatitis B Virus
  •       - 13.7: Human Immunodeficiency Virus
  • • Chapter 14: Other Infections Download PDF
  •       - 14.1: Urinary Tract Infection
  •       - 14.2: Pneumocystis Jirovecii Pneumonia
  •       - 14.3: Tuberculosis
  •       - 14.4: Candida Prophylaxis
Section III - Introduction: Cardiovascular Disease Download PDF
  • • Chapter 15: Diabetes Mellitus Download PDF
  •       - 15.1: Screening for New-Onset Diabetes after Transplantation
  •       - 15.2: Managing NODAT or Diabetes Present at Transplantation
  • • Chapter 16: Hypertension, Dyslipidemias, Tobacco Use, and Obesity Download PDF
  •       - 16.1: Hypertension
  •       - 16.2: Dyslipidemias
  •       - 16.3: Tobacco Use
  •       - 16.4: Obesity
  • • Chapter 17: Cardiovascular Disease Management Download PDF
Section IV - Introduction: Malignancy Download PDF
  • • Chapter 18: Cancer of the Skin and Lip Download PDF
  • • Chapter 19: Non–Skin Malignancies Download PDF
  • • Chapter 20: Managing Cancer with Reduction of Immunosuppressive Medication Download PDF
Section V - Introduction: Other Complications Download PDF
  • • Chapter 21: Transplant Bone Disease Download PDF
  • • Chapter 22: Hematological Complications Download PDF
  • • Chapter 23: Hyperuricemia and Gout Download PDF
  • • Chapter 24: Growth and Development Download PDF
  • • Chapter 25: Sexual Function and Fertility Download PDF
  •       - 25.1: Sexual Function
  •       - 25.2: Female Fertility
  •       - 25.3: Male Fertility
  • • Chapter 26: Lifestyle Download PDF
  • • Chapter 27: Mental Health Download PDF